Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?
Harbarth
Stephan
S
Garbino
Jorge
J
Pittet
Didier
D
Pugin
Jérome
J
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D015331:Cohort Studies; D004311:Double-Blind Method; D006801:Humans; D007769:Lactams / Q000627:therapeutic use; D051379:Mice; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000401:mortality*; D012189:Retrospective Studies; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology / Q000401:mortality*; D016019:Survival Analysis; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000900:Anti-Bacterial Agents; D000906:Antibodies; D007769:Lactams; D014409:Tumor Necrosis Factor-alpha